Primary primitive neuroectodermal tumour of the urinary bladder: a clinico-pathological study emphasising immunohistochemical, ultrastructural and molecular analyses

Primary primitive neuroectodermal tumours (PNETs) of the bladder are extremely rare and aggressive neoplasms, and only six examples have been reported in the literature. The case of a 21-year-old woman, who remains disease free 3 years after tumour resection, is reported here. Morphological features were found to correspond to a small round blue cell tumour without rosette formation and with extensive areas of necrosis. Strong expression of CD99, vimentin and CD117 (c-kit), and focal reactivity to cytokeratin and S-100 protein was observed in tumour cells. Ultrastructurally, sparse neurosecretory granules were observed. Diagnosis of PNET was supported by molecular genetic analysis, showing the EWS–FLI-1 fusion transcript type 2 by RT-PCR and EWS gene rearrangement by fluorescence in situ hybridisation. A normal genetically balanced genotype was shown by comparative genomic hybridisation, which, together with the expression of c-kit, a known therapeutic target for imatinib, may have prognostic and therapeutic implications.

[1]  J. Montie Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 64 patients. , 2005, The Journal of urology.

[2]  E. Andreu,et al.  Imatinib Inhibits Proliferation of Ewing Tumor Cells Mediated by the Stem Cell Factor/KIT Receptor Pathway, and Sensitizes Cells to Vincristine and Doxorubicin-Induced Apoptosis , 2004, Clinical Cancer Research.

[3]  I. Yaniv,et al.  Molecular cytogenetic parameters in Ewing sarcoma. , 2003, Cancer genetics and cytogenetics.

[4]  A. Feller,et al.  Primitive neuroectodermal tumor (PNET) of the urinary bladder. , 2003, Pathology, research and practice.

[5]  T. Merchant,et al.  Survival after recurrence of Ewing Tumors , 2002, Cancer.

[6]  S. Pilotti,et al.  Immunophenotypic and genotypic analysis of a case of primary peripheral primitive neuroectodermal tumour (pPNET) of the urinary bladder , 2002, Histopathology.

[7]  E. de Álava,et al.  Ewing Tumor: Tumor Biology and Clinical Applications , 2001, International journal of surgical pathology.

[8]  Desai,et al.  Primary primitive neuroectodermal tumour of the urinary bladder , 1998, Histopathology.

[9]  W. Gerald,et al.  EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  H. Mentzel,et al.  [Primary primitive neuroectodermal tumor of the urinary bladder. Clinicopathologic case report and differential small cell tumor diagnosis of this site]. , 1998, Der Pathologe.

[11]  D. Roth,et al.  Primary Ewing's sarcoma of the bladder associated with an elevated antinuclear antibody titer. , 1997, The Journal of urology.

[12]  B. Eyden,et al.  Primary peripheral primitive neuroectodermal tumour of urinary bladder , 1997, Histopathology.

[13]  D. Grignon,et al.  Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 22 cases , 1992, Cancer.